2016 American Transplant Congress
Clinical and Subclinical Cardiac Events After Kidney Transplantation (KTX).
Introduction. Elevated levels of the biomarker cardiac troponin T levels (cTNT) pre- KTX relates to high mortality and CV risk pre and post-KTX. We sought…2016 American Transplant Congress
U.S. Dialysis Facility Characteristics Associated with Racial Disparities in Access to the Kidney Deceased Donor Transplant Waiting List.
BACKGROUND Dialysis facility characteristics have been significantly associated with variation in U.S. transplant rates but facility characteristics associated with disparities in access to the kidney…2016 American Transplant Congress
Outcomes of Donor Nephrectomy in the Elderly.
PURPOSE: The critical organ shortage has increased demand for marginal donor kidneys. Although previously a contraindication to live kidney donation, advanced age donors (>60 y.o.)…2016 American Transplant Congress
Socioeconomic Status and Readmission Following Kidney Transplant.
Transplant Surgery, Johns Hopkins Hospital, Baltimore.
Our group has previously demonstrated that 31% of kidney transplant recipients are readmitted within 30 days of discharge from the original hospitalization. Patient-level contributors such…2016 American Transplant Congress
Early Impact of the New Kidney Allocation System (KAS) in Highly Sensitized Patients.
University of Alabama at Birmingham, Birmingham, AL.
PurposeHighly sensitized (HS) patients, defined as a PRA of 99-100% are awarded additional priority points in the new KAS instituted December 2014. We evaluated the…2016 American Transplant Congress
Effect of Baseline Proteinuria on Long- and Short-Term Outcomes in Live Kidney Donors – 10 Year U.K Cohort Study.
Living kidney donation has significantly improved recipient and graft survival world wide. It is importanat to have a better understanding of the outcomes and risks…2016 American Transplant Congress
A Prospective Carfilzomib-Based Desensitization Trial: Phase 1 Results.
1U Of Cincinnati, Cincinnati; 2Mayo Clinic, Phoenix.
Carfilzomib (CFZ) is mechanistically distinct from bortezomib as it is an irreversible PI. Results from phase 1 of a CFZ desensitization (DS) trial are presentedMethods:…2016 American Transplant Congress
Does DCD Donor Time-to-Death After Withdrawal of Support Affect Recipient Outcomes? Implications of Time-to-Death at a High-Volume Center in the United States.
Surgery, University of Wisconsin, Madison, WI.
Introduction: Donation after circulatory death (DCD) kidneys represent 15% of the deceased donor kidneys transplanted in the United States. A majority of transplant centers will…2016 American Transplant Congress
Gender Differences in Longitudinal eGFR of Living Kidney Donors in a Health Information Exchange.
Background: The trajectory of post-donation eGFR in living donors is poorly described. Our objective was to explore the association between baseline donor characteristics and post-donation…2016 American Transplant Congress
Utility of a Scoring Tool for Living Kidney Donor Volunteers.
A comprehensive yet efficient evaluation of living kidney donor volunteers (LKDV) is key to a successful transplant program. Donor selection is complex and must balance…
- « Previous Page
- 1
- …
- 92
- 93
- 94
- 95
- 96
- …
- 101
- Next Page »